Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol and/or vaginal dilators to prevent vaginal stenosis after radiotherapy for cervical cancer
RBR-2258hp5Phase 2Not yet recruiting
- Sponsor
- Universidade Estadual de Campinas
- Start
- Oct 2024
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of estradiol in vaginal stenosis, vaginal atrophy and menopause (3 arms), sponsored by Universidade Estadual de Campinas. Primary endpoint: Vaginal stenosis prevention. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
estradiol
03
Conditions
vaginal stenosisvaginal atrophymenopause
Beyond the preview
Go deeper on RBR-2258hp5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2258hp5.